StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
OFIX

Orthofix Medical Inc.

OFIX Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$12.26
+0.47 +3.99%

Key statistics

from XBRL data in SEC filings
Market cap
$496M
Revenue (TTM)
$825M
Net income (TTM)
-$60.0M
EPS (TTM)
$-1.50
P/E ratio
Dividend yield
Free cash flow
-$1.28M
Cash
$120M
Total assets
$887M
Gross margin
70.7%
52-week range
$8.85 – $16.99

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jul 2, 2026 8-K Director or officer change; Shareholder vote results Jun 11, 2026 8-K Regulation FD disclosure May 21, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 5, 2026 8-K Results of operations (earnings release); Director or officer change Apr 9, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 24, 2026 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 5, 2025 8-K Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2025 8-K Entered a material agreement; Terminated a material agreement Apr 7, 2025 8-K Director or officer change; Regulation FD disclosure Mar 12, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 25, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 6, 2024 8-K Director or officer change; Shareholder vote results Jun 20, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2024 8-K Entered a material agreement Apr 22, 2024 8-K Director or officer change Apr 12, 2024 10-K Fiscal year ended 2023-12-31 Mar 5, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 5, 2024 8-K Director or officer change; Regulation FD disclosure Jan 17, 2024 8-K Results of operations (earnings release); Director or officer change Jan 9, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K Entered a material agreement; Director or officer change; Other events Dec 15, 2023 8-K Director or officer change; Regulation FD disclosure Dec 1, 2023 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 8, 2023 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Nov 8, 2023 8-K Director or officer change Oct 5, 2023